Table 4.
EBC experiment and analysis parameters for studies of EBC in schizophrenia.
| Study | Experiment parameters |
Dependent variable quantification criteria |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ISI (ms) | Mean ITI (s) | Number of blocks | Trialsper block | Total trials(no. ofblocks) | Total no. paired trials | Pre-conditioning trials | Extinction trials | CR criterion (amplitude) | CR window (post-CS latency ms) | |
| Taylor and Spence (54) | 470 | 20 | 1 | 80 | 80 (1) | 80 | 3 CS-alone, 1 US-alone | – | ≥1 mm deflection of eyelid closure movement on polygraph (70) | 200–470 |
| O’Connor and Rawnsley (55) | 350 | Random b/t 20 and 40 | 1 | 48 | 48 (1) | 30 | 3 CS-alone, 3 US-alone, 3 CS-alone | – | On CS-alone trials (n = 18) only: response amplitude 150% of maximum baseline amplitude (when cue light turned on before trial, 3–7 s pre-CS) | 0–1.25 s post-CS onset for CS-alone test trials only |
| Spain (56) | ||||||||||
| Auditory | 500 | 20 ms | 1 | 50 | 50 (1) | 50 | – | – | Non-voluntary eyelid movement | 200–500 |
| Visual | 500 | 20 ms | 1 | 50 | 50 (1) | 50 | – | – | Non-voluntary eyelid movement | 200–500 |
| Sears et al. (57) | 400 | 12 | 1 | 70 | 70 (1) | 63 | 10 US-alone trials | 40 unpaired CS or US trials | Amplitude exceeds 10% of baseline UR amplitude (measured from 10 US-alone trials pre-conditioning) for paired and CS-alone trials | 200–400 |
| Hofer et al. (58) | 720 | 12 | 6 | 12 | 72 (6) | 48 | – | – | Change in the curve of eyelid data waveform exceeds 0.4 cm for at least 30 ms on S+ and S− trials (71) | 390–720 |
| Stevens et al. (59) | 700 | 1100 ms | 1 | 70 | 70 (1) | – | – | – | – | Eyeblink response must occur 200–700 post-CS onset on S+ and S− trials |
| Marenco et al. (60) | ||||||||||
| Trace | 1540 | 18 | 7 | 11 | 77 (7) | 70 | 10 CS-alone and 10 US-alone randomly presented | 10 CS-alone and 10 US-alone randomly presented | Eyelid movement ≥0.5 mm for paired and CS-alone trials | 150–1540 |
| Delay | 440 | 18 | 7 | 11 | 77 (7) | 70 | 10 CS-alone and 10 US-alone randomly presented | 10 CS-alone and 10 US-alone randomly presented | Eyelid movement ≥0.5 mm for paired and CS-alone trials | 150–440 |
| Brown et al. (61) | 350 | 15 | 10 | 10 | 100 (10) | 90 | 8 US-alone trials | 20 CS-alone and 20 US-alone randomly presented | EMG amplitude over 5 SDs above pre-CS 125 ms baseline for each paired trial | 100–350 |
| Edwards et al. (62) | 350 | 15 | 10 | 10 | 100 (10) | 90 | 8 US-alone trials | – | EMG amplitude over 5 SDs above pre-CS 225 ms baseline for each paired trial | 100–350 |
| Bolbecker et al. (63) | 350 | 15 | 10 | 10 | 100 (10) | 90 | 8 US-alone trials | 25 CS-alone and 25 US-alone randomly presented | EMG amplitude over 5 SDs above pre-CS 125 ms baseline for each paired trial | 100–350 |
| Bolbecker et al. (64) | 250; 350; 550; 850 | 15 | For each ISI: 5 (total = 10) | 20 | For each ISI: 100 (5) [total = 200 (10)] | For each ISI: 90 (total = 180) | 8 US-alone trials | – | EMG amplitude over 5 SDs above pre-CS 125 ms baseline for each paired trial | 150 pre-US onset |
| Forsyth et al. (65) | 350 | 15 | 10 | 10 | 100 (10) | 90 | 8 US-alone trials | – | EMG amplitude over 5 SDs above pre-CS 125 ms baseline for each paired trial | 100–350 |
| Parker et al. (66) | 400 | 12 | 3 | 15 | 45 (3) | 45 | 10 (5 CS-alone trials and 5 US-alone trials) | 3 blocks of 30 extinction trials, each consisting of 20 CS-alone trials followed by 5 CS-alone and 5 US-alone trials presented pseudorandomly | Eyeblink amplitude exceeding 10% of baseline UR amplitude (measured during pseudoconditioning US-alone trials) | 200–400 |
| Bolbecker et al. (67) | 350 | 15 | 10 | 10 | 100 (10) | 90 | 8 US-alone trials | – | EMG amplitude over 5 SDs above pre-CS 125 ms baseline for each paired trial | 100–350 |
| Coesmans et al. (68) | 500 | Random intervals b/t 20 and 30 | 10 | 8 | 80 (10) | 60 | – | – | For paired and CS-alone trials, maximum eyelid closure occurring between 100 and 800 ms post-CS onset was first calculated. Blinks then classified as CRs if blink onset occurred within CR window (72) | 150–525 |